| Table 2. The effect of fresh cycle stimulation characteristics on thaw cycle outcomes | ||||||
| Survival rate Mean ± SD Total cases n=104 |
p-value | Progression rate N (%) Total Survived n=94 |
p-value | Pregnancy rate N (%) Transferred n=84 |
p-value | |
| Protocol type: | 0.87** | 0.94**** | 0.58**** | |||
| Antagonist | 84.9±33.4 | 17/23 (73.9%) | 4/21 (19.1%) | |||
| Long agonist | 82.6±36 | 45/66 (68.2%) | 19/59 (32.2%) | |||
| Short agonist | 90±22.4 | 4/5 (80%) | 1/4 (25%) | |||
| Stimulation drug: | 0.05* | 0.01*** | 0.57*** | |||
| FSH | 76.9±38 | 28/46 (60.9%) | 10/39 (25.6%) | |||
| FSH/LH | 90.1±29.7 | 38/48 (79.2%) | 14/45 (31.1%) | |||
| Endometrial thickness | 0.96* | 0.62*** | 0.84*** | |||
| ≤1cm | 83.4±33.8 | 32/44 (72.7%) | 11/40 (27.5%) | |||
| > 1cm | 83.7±35.8 | 34/50 (68%) | 13/44 (29.6%) | |||
| Endometrial grading: | 0.61** | 0.98*** | 0.35**** | |||
| A | 86.6±30.6 | 7/10 (70%) | 4/10 (40%) | |||
| B | 87.6±30.5 | 22/32 (68.8%) | 9/26 (34.6%) | |||
| C | 80.6±37.8 | 37/52 (71.2%) | 11/48 (22.9%) | |||
| Indication of freezing: | 0.73** | 0.84**** | 0.05*** | |||
| Excess | 82.4±35.7 | 48/68 (70.6%) | 22/62 (35.4%) | |||
| OHSS | 85.8±33.3 | 16/24 (66.7%) | 2/20 (10%) | |||
| Thin endometrium | 100±0 | 2/2 (100%) | 0/2 (0%) | |||
| Outcome of 1stcycle: | 0.78** | 0.68*** | <0.0001**** | |||
| No pregnancy | 85.7±31.8 | 24/36 (66.7%) | 4/33 (12.1%) | |||
| Pregnancy | 80.5±38.3 | 27/35 (77.1%) | 18/32 (56.3%) | |||
| No ET | 85.2±33.8 | 15/23 (65.2%) | 2/19 (10.5%) | |||
| *Unpaired T test **one way ANOVA ***Chi square test ****Fisher-Freeman-Halton exact | ||||||